Immunisations and chemoprophylaxis Flashcards
8 weeks old
- Diphtheria
- tetanus
- pertussis (whooping cough)
- polio
- Haemophilus influenzae type b (Hib)
- hepatitis B
Meningococcal group B (MenB)
Rotavirus
12 weeks old
- Diphtheria
- tetanus
- pertussis
- polio
- Hib
- hepatitis B
Pneumococcal (13 serotypes)
Rotavirus
16 weeks old
- Diphtheria
- tetanus
- pertussis
- polio
- Hib
- hepatitis B
MenB
1 years old
Hib and Meningococcal group C (MenC)
Pneumococcal (booster)
Measles, mumps and rubella (German measles)
MenB (booster)
3 years 4 months old or soon after
Diphtheria
tetanus
pertussis
polio
MMR
Boys and girls aged 12 to 13 years
HPV (2 doses 6 to 24 months apart)
14 years old (school Year 9)
Tetanus
diphtheria
polio
Meningococcal groups A, C, W and Y
65 years old
Pneumococcal (23 serotypes)
65 years of age and older
Influenza (each year from September)
70 to 79 years of age
Shingles
Babies born to hepatitis B infected mothers
Hepatitis B vaccine at birth, 4 weeks and 12 months old
Infants in areas of the country with tuberculosis (TB) incidence >= 40/100,000 or Infants with a parent or grandparent born in a high incidence country
Tuberculosis BCG vaccine given at Around 28 days old
Children in a clinical risk group from 6 months to 17 years of age
Influenza
Pregnant women
At any stage of pregnancy during flu season- influenza inactivated flu vaccine
From 16 weeks gestation - pertussis
Asplenia or splenic dysfunction (including due to sickle cell and coeliac disease)
Meningococcal groups A, B, C, W and Y vaccine
Pneumococcal
influenza annual flu vaccine
Cochlear implants
Pneumococcal
Chronic respiratory and heart conditions (such as severe asthma, chronic pulmonary disease, and heart failure)
pneumococcal
influenza
Chronic neurological conditions (such as Parkinson’s or motor neurone disease, or learning disability)
pneumococcal
influenza
diabetes
pneumococcal
influenza
Chronic kidney disease (CKD) (including haemodialysis)
Pneumococcal (stage 4 and 5 CKD)
Influenza (stage 3, 4 and 5 CKD)
Hepatitis B (stage 4 and 5 CKD)
Chronic liver conditions
Pneumococcal
Influenza
Hepatitis A,B
Haemophilia
Hepatitis A, B
Immunosuppression due to disease or treatment
pneumococcal
influenza
Complement disorders (including those receiving complement inhibitor therapy)
Meningococcal groups A, B, C, W and Y
Pneumococcal
Influenza
live-attenuated (may pose a risk to immunocompromised patients)
BCG measles, mumps, rubella (MMR) influenza (intranasal) oral rotavirus oral polio (historic) yellow fever oral typhoid
Inactivated preparations
rabies
hepatitis A
influenza (intramuscular)
polio ( currently used in UK)
Toxoid (inactivated toxin)
tetanus
diphtheria
pertussis
Meningitis post exposure prophylaxis
single dose of ciprofloxacin ideally within 24 hours of the initial diagnosis.The risk is highest in the first 7 days after a case is diagnosed and falls sharply thereafter.
HIV Post Exposure Prophylaxis
must be commenced within 72h
Truvada (emtricitabine / tenofovir) and raltegravir for 28 days.
HIV tests should be done initially but also a minimum of 3 months after exposure to confirm a negative status. Individuals should abstain from unprotected activity for a minimum of 3 months until confirmed negative.
